dichlororibofuranosylbenzimidazole has been researched along with Familial Primary Pulmonary Hypertension in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Familial Primary Pulmonary Hypertension: Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JE | 1 |
| Yang, YM | 1 |
| Liang, FX | 1 |
| Gough, DJ | 1 |
| Levy, DE | 1 |
| Sehgal, PB | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Familial Primary Pulmonary Hypertension
| Article | Year |
|---|---|
Nongenomic STAT5-dependent effects on Golgi apparatus and endoplasmic reticulum structure and function.
Topics: Animals; Cattle; Cell Nucleus; Cells, Cultured; Centrosome; Cytoplasm; Dichlororibofuranosylbenzimid | 2012 |